AdaptHealth Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-74.83	-66.04	94.78	-674.78	73.13	158.15
Depreciation & Amortization	394.05	381.93	365.33	382.78	351.18	258.05
Stock-Based Compensation	23.11	21.88	14.88	22.47	22.4	25.32
Other Adjustments	210.37	197.43	92.9	775.3	35.16	-12.54
Change in Receivables	25.35	30.99	-26.22	-28.86	-0.21	-29.69
Changes in Inventories	-28.4	-11.49	-28.07	15.53	-6.3	-14.92
Changes in Other Operating Activities	63.44	47.08	28.22	-11.78	-101.49	-108.7
Operating Cash Flow	599.97	601.77	541.84	480.67	373.87	275.68
Operating Cash Flow Growth	1.98%	11.06%	12.73%	28.57%	35.62%	40.92%
Capital Expenditures	-408.02	-382.39	-306.06	-337.46	-391.42	-203.31
Sale of Property, Plant & Equipment	1.44	-	5.32	-	-	-
Purchases of Investments	-	-	-	-0.13	-0.73	-1.13
Payments for Business Acquisitions	-127.06	-42.38	-9.54	-19.69	-19.02	-1,620
Proceeds from Business Divestments	63.16	121.58	-	-	-	-
Investing Cash Flow	-412.06	-303.19	-310.28	-357.28	-411.17	-1,825
Long-Term Debt Issued	100	-	253.48	50	-	2,265
Long-Term Debt Repaid	-239.06	-250	-423.48	-95	-20	-827.27
Net Long-Term Debt Issued (Repaid)	-139.06	-250	-170	-45	-20	1,438
Issuance of Common Stock	1.11	1.21	1.74	2.62	4.13	292.19
Repurchase of Common Stock	-	-	-	-29.28	-13.99	-
Net Common Stock Issued (Repurchased)	1.11	1.21	1.74	-26.66	-9.87	292.19
Other Financing Activities	-55.53	-53.4	-30.69	-20.87	-36.19	-131.18
Financing Cash Flow	-193.59	-302.19	-198.95	-92.53	-66.05	1,599
Net Cash Flow	-5.69	-3.61	32.62	30.86	-103.36	49.67
Free Cash Flow	191.95	219.38	235.78	143.2	-17.56	72.37
Free Cash Flow Growth	-12.50%	-6.96%	64.65%	-	-	-53.57%
FCF Margin	5.84%	6.76%	7.23%	4.47%	-0.59%	2.95%
Free Cash Flow Per Share	1.41	1.62	1.74	1.07	-0.08	0.54
Levered Free Cash Flow	-134.03	-285.66	-20.14	-674.82	-98.72	1,525
Unlevered Free Cash Flow	90.15	431.14	243.21	-508.81	-5.79	117.98

SEC Filings: 10-K · 10-Q